FDA
National Alliance for Hispanic Health Cautions FDA on 2022 Report on the Risks and Health Benefits of Non-device Software
WASHINGTON, July 18, 2022 /PRNewswire/ — “The COVID pandemic has changed the acceptance of mHealth throughout the Nation. There is an u...
Statement of Jane L. Delgado, PhD, MS, President and CEO of the National Alliance for Hispanic Health on FDA Action Denying Marketing Applications ...
FDA action will save lives; it is also time to deny applications for all flavored e-cigarettes
WASHINGTON, June 23, 2022 /PRNewswire-HISPANIC PR WI...
The FDA weighs in on market research and drug developers are listening – especially to the underserved – PharmaLive
The FDA weighs in on market research and drug developers are listening – especially to the underserved
By Fabio Gratton
A new era of FDA guidance
T...
Exactech Announces FDA Breakthrough Device Designation for JointMedica's Polymotion® Hip Resurfacing System
[May 17, 2022]
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery...
FDA Pushes Enrollment of Underrepresented Populations in Clinical Trials with Recent ‘Race and Ethnicity Diversity Plan’ Draft Guidance
Jacob Simpson
...
Why Do Clinical Trials Still Underrepresent Minority Groups?
It’s no secret that, for decades, the participants in clinical trials for new drugs and medical devices haven’t accurately represented ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
